BioSpace News Archive

International medical imaging IT and cybersecurity company Sectra will install the radiology module of its enterprise imaging solution throughout UNC Health.

Vernal Biosciences, Inc., a manufacturer of high purity mRNA for research and clinical use, today announced the closing of a seed round of financing.

Gnubiotics Announces Self-Affirmed GRAS Designation of GNUbiome FI

Allogene Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of allogeneic CAR T therapies for cancer, announced that management plans to participate in two upcoming virtual investor conferences.

A number of methods in cell lysis market are used for cell lysis or cell fractionation, which mainly consist of disintegration of cell membranes partially or fully to obtain inter-cellular materials.

The antiseptic and disinfectant market survey offers insights into chief growth drivers and restrains impacting the overall growth trajectory.

MaxCyte, Inc., a leading provider of platform technologies for cell engineering, announced the public filing of a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed dual-listing and public offering of shares of common stock on the Nasdaq Stock Market.

Pharnext SA, an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence using its PLEOTHERAPY platform, announces the enrollment of the first patient in Europe in its pivotal Phase III clinical study of PXT3003 in Charcot-Marie-Tooth disease type 1A.

Daré Bioscience, Inc. announced that it entered into a Cooperative Research and Development Agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health, for the pivotal Phase 3 study of Ovaprene®, an investigational hormone-free monthly intravaginal contraceptive currently in clinical development for the prevention of pregnancy.

Three oncology practices with a combined total of ten physicians have recently joined The Center for Cancer and Blood Disorders, the growing North Texas independent oncology practice, an affiliate of OneOncology, announced.